Results 231 to 240 of about 1,544,422 (378)

Improving genetic diagnosis of hereditary tumor syndromes: From expanded gene panels to functional genomics

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Genetic tumor risk syndromes (genturis) contribute substantially to the overall cancer burden and provide opportunities for early detection, prevention, and individualized treatment. Yet, many affected individuals remain undiagnosed due to restrictive testing criteria and challenges in variant interpretation.
Mayra Sauer   +11 more
wiley   +1 more source

Fragile X syndrome due to a missense mutation

open access: yesEuropean Journal of Human Genetics, 2014
L. K. Myrick   +5 more
semanticscholar   +1 more source

A missense mutation in Muc2 promotes gut microbiome and metabolome-dependent colitis-associated tumorigenesis. [PDF]

open access: yesJ Clin Invest
Verna G   +14 more
europepmc   +1 more source

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja   +11 more
wiley   +1 more source

A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS.

open access: yesJournal of the American Society of Nephrology, 2014
Evelyne Huynh Cong   +23 more
semanticscholar   +1 more source

Sideroblastic anemia: functional study of two novel missense mutations in ALAS2 [PDF]

open access: gold, 2016
Manuel Méndez   +5 more
openalex   +1 more source

Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives

open access: yesJournal of Intelligent Medicine, EarlyView.
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan   +3 more
wiley   +1 more source

A novel MKRN3 missense mutation causing familial precocious puberty.

open access: yesHuman Reproduction, 2014
L. D. Vries   +8 more
semanticscholar   +1 more source

Supplementary Table 6 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling [PDF]

open access: gold
Ruyi Zhang   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy